Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Pancreatic neuroendocrine tumors: Signal pathways and targeted therapies
L. Peng
, R. E. Schwarz
Pathology
Pathology
Surgery
Research output
:
Contribution to journal
›
Review article
›
peer-review
12
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pancreatic neuroendocrine tumors: Signal pathways and targeted therapies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Chemical Compounds
Everolimus
100%
Sunitinib
95%
Streptozocin
56%
Tyrosine
26%
Medicine & Life Sciences
Neuroendocrine Tumors
64%
Signal Transduction
44%
Sunitinib
24%
Everolimus
24%
Biological Therapy
11%
TOR Serine-Threonine Kinases
10%
Streptozocin
9%
United States Food and Drug Administration
9%
Therapeutics
9%
Protein-Tyrosine Kinases
8%
Neoplasms
3%